The case of Bertila Boyd-Bostic, who died of a rare form of cancer
in 2017 at the age of 30, is the latest in a series of trials in the
United States that center around allegations that the company's
talc-based powder contains cancer-causing asbestos.
In May, a deadlocked jury at the Darlington County Court of Common
Pleas in Charleston failed to reach a verdict in the first trial.
J&J, which denies the allegations, to date has lost two trials and
won three in the litigation over whether Johnson's Baby Powder
causes mesothelioma, a tissue cancer closely linked to asbestos
exposure. Jury trials in another four mesothelioma cases have
resulted in mistrials because jurors could not agree on a verdict or
because the plaintiff died.
J&J, faced with some 11,700 U.S. talc lawsuits, in a statement on
Thursday said it believed the mistrials, as well as the verdicts
clearing it of liability reflected the "diligent review" by juries
in the cases.
"We look forward to a new trial to present our defense, which rests
on decades of independent, non-litigation-driven scientific
evaluations, none of which have found that Johnson's Baby Powder
contains asbestos," the company said.
Christopher Swett, a lawyer for Boyd-Bostic's family, in a statement
said plaintiffs were disappointed with Thursday's result. Swett said
the trial court judge had urged the parties to consider a
settlement, but that J&J "refuses to be reasonable and take
responsibility."
[to top of second column] |
The New Brunswick, New Jersey-based company in the past has said
that it was not considering to settle talc cases and currently is
appealing all jury verdicts against it.
Of the 11,700 talc lawsuits, more than 9,700 involve claims over
ovarian cancer, recent filings in federal court in New Jersey, where
most of the cases are consolidated, showed.
The remaining plaintiffs allege asbestos in J&J's talc caused them
to develop mesothelioma.
J&J has been fighting talc cancer lawsuits for several years, but
the litigation shifted in recent months to include allegations of
asbestos contamination.
In July, a Missouri jury hit J&J with a massive $4.69 billion
verdict in the first trial alleging asbestos contamination has
caused ovarian cancer in 22 women. That decision is under appeal.
(Reporting by Tina Bellon; Editing by Leslie Adler)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|